Analyst firms · Piper Sandler · RAPT

Piper Sandler RAPT price target and rating history

RAPT Therapeutics Inc. (RAPT) · Health Care

Piper Sandler rates RAPT Therapeutics Inc. (RAPT) Overweight with a $95 price target, as of its latest action on Jan 9, 2026. It has published 3 rating actions on RAPT since March 2022, including 0 upgrades and 1 downgrade.

Current rating
Overweight
Price target
$95
Median target, all firms
Too few
Actions on RAPT
3

Piper Sandler price target on RAPT

$95$49$22023202420252026
Piper Sandler price target on RAPT, each point a stated target, March 2022 to January 2026.

Every Piper Sandler rating on RAPT

Questions about Piper Sandler and RAPT

What is Piper Sandler's price target for RAPT?
Piper Sandler's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $95, from its action on Jan 9, 2026.
What is Piper Sandler's rating on RAPT?
Piper Sandler rates RAPT Overweight, a bullish rating, as of Jan 9, 2026.
When did Piper Sandler last change its view on RAPT?
On Jan 9, 2026, Piper Sandler starts coverage at Overweight, price target $95.

More RAPT rating histories

All Piper Sandler ratingsRAPT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.